Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2007 1
2013 3
2014 4
2015 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Wang M, Maisnar V, Minarik J, Bensinger WI, Mateos MV, Ben-Yehuda D, Kukreti V, Zojwalla N, Tonda ME, Yang X, Xing B, Moreau P, Palumbo A; ASPIRE Investigators. Stewart AK, et al. N Engl J Med. 2015 Jan 8;372(2):142-52. doi: 10.1056/NEJMoa1411321. Epub 2014 Dec 6. N Engl J Med. 2015. PMID: 25482145 Free article. Clinical Trial.
Anaplastic plasmacytoma of the kidney.
Fan F, Deauna-Limayo D, Brantley Thrasher J, Damjanov I. Fan F, et al. Among authors: deauna limayo d. Histopathology. 2005 Oct;47(4):432-3. doi: 10.1111/j.1365-2559.2005.02123.x. Histopathology. 2005. PMID: 16178900 No abstract available.
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.
Byrd JC, Pagel JM, Awan FT, Forero A, Flinn IW, Deauna-Limayo DP, Spurgeon SE, Andritsos LA, Gopal AK, Leonard JP, Eisenfeld AJ, Bannink JE, Stromatt SC, Furman RR. Byrd JC, et al. Among authors: deauna limayo dp. Blood. 2014 Feb 27;123(9):1302-8. doi: 10.1182/blood-2013-07-512137. Epub 2013 Dec 31. Blood. 2014. PMID: 24381226 Free PMC article. Clinical Trial.
Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experience.
Ganguly S, Singh J, Divine CL, Deauna-Limayo D, Bodensteiner DC, Lewis JL, Curran K, Skikne BS. Ganguly S, et al. Among authors: deauna limayo d. Leuk Res. 2007 Sep;31(9):1253-7. doi: 10.1016/j.leukres.2006.12.021. Epub 2007 Feb 22. Leuk Res. 2007. PMID: 17320953 Clinical Trial.
Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
Deauna-Limayo D, Aljitawi OS, Ganguly S, Abhyankar S, Wick JA, McGuirk JP. Deauna-Limayo D, et al. J Oncol Pharm Pract. 2014 Aug;20(4):263-9. doi: 10.1177/1078155213502103. Epub 2013 Sep 4. J Oncol Pharm Pract. 2014. PMID: 24005093
Kaposi sarcoma after non-myeloablative hematopoietic stem cell transplant: response to withdrawal of immunosuppressant therapy correlated with whole blood human herpesvirus-8 reverse transcriptase-polymerase chain reaction levels.
Deauna-Limayo D, Rajabi B, Qiu W, Htut M, Sweetenham J. Deauna-Limayo D, et al. Leuk Lymphoma. 2013 Oct;54(10):2299-302. doi: 10.3109/10428194.2013.769221. Epub 2013 May 15. Leuk Lymphoma. 2013. PMID: 23343181 No abstract available.
11 results